Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression.

Category Primary study
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2024
This case-control study explored cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatis B virus (HIV/HBV) coinfection with HIV viral suppression. Among patients taking tenofovir disoproxil fumarate, median TFV-DP levels in dried blood spots were ∼3-fold lower among patients with incomplete HBV viral suppression (n = 4) compared to those with complete suppression (n = 5) (516 vs 1456 fmol/punch).
Epistemonikos ID: d16eb64d7cef19d87ddbbde3c412c7e452467e08
First added on: Nov 10, 2024